MIRIXA Australia and
GlaxoSmithKline will launch a new
‘Seretide New to Therapy’ program
at the beginning of next month.
The program allows pharmacists
to use a clinical system to initiate
patients starting or re-starting
Seretide, then follow up with them
a month later.
Professional service fees will be
paid to the pharmacy per patient
session, with Guild President Kos
Sclavos saying the program “is a
natural fit to the role pharmacists
play when initiating patients.
“Because this is something we
usually do anyway, pharmacists can
now use a good clinical system with
excellent patient support materials.
“The result is quality time spent
with the patient, confidence in
counselling and potentially greater
patient outcomes,” he added.The above article was sent to subscribers in Pharmacy Daily's issue from 28 Oct 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Oct 10
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
PHARMACY Connect (PC2024) has revealed that Olympian Peter Bol will be sharing his journey from adversity to athletic greatness at the conference in Sep in Sydney.
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.